FDA approves 2 drugs from Mass. biotechs
A Vertex Pharmaceuticals treatment for cystic fibrosis and an Ironwood Pharmaceuticals drug to treat irritable bowel disease got approval from the US Food and Drug Administration. Pictured is Eric Olson, vice president of the cystic fibrosis franchise at Vertex Pharmaceuticals, holding two Kalydeco pills to treat cystic fibrosis in his office in Cambridge.
The Boston Globe/File
- Choose another
-
- Page 1
- Amazon to collect sales tax from Mass. residents
- A123 Systems Inc. files for bankruptcy
- NStar agrees to buy Cape Wind power
- Nonstop flights from Boston to Toyko begin
- Superstar pay for Liberty Mutual’s Ted Kelly
- Curt Schilling’s 38 Studios goes bankrupt
- Upper Crust goes bankrupt
- Investigation launched into alleged racial profiling at Logan
- Priceline buys Kayak
- National fungal meningitis outbreak tied to Mass. firm
- Mass. economy slows
- Redevelopment of Filene’s site begins anew
- Still fishy
- Labor violations at the Boston Marriott Copley Plaza’s renovation
- Housing market rebounds
- Apartment boom
- Amazon buys robot maker Kiva
- Tough year for the ski industry
- Pax East to stay in Boston
- FDA approves 2 drugs from Mass. biotechs
- OneUnited Bank threatens to auction off Charles Street AME Church
- State AGs reach $25b mortgage fraud settlement
- Romney’s handling of the Mass. economy
- Safety practices of Walmart contractors questioned
Advertisement